Vagus nerve stimulation market to be valued at $23.73b by 2031

The industry is driven by the development of minimally invasive solutions.

The global vagus nerve stimulation (VNS) market is expected to reach US$23.73b by 2031, growing at a CAGR of 10.5%, according to Verified Market Research.

The industry’s expansion is attributed to the growing prevalence of neurological diseases, growing demand for non-invasive treatment solutions, and increasing clinical approvals.

The development of minimally invasive and non-invasive VNS solutions is also driving market growth.

“Manufacturers are launching compact, wearable, user-friendly devices with enhanced security, higher battery efficiency, wireless connectivity and artificial intelligence-based monitoring capabilities,” the report said.

Additionally, growing adoption in epilepsy, depression, migraine, and chronic pain management is further driving adoption as governments, hospitals, and private healthcare organizations invest heavily in advanced neurological care infrastructure.

However, high device costs, surgical risk concerns and a strict regulatory pathway may limit growth.

“For many health care systems, especially in developing regions, budget constraints and limited reimbursement coverage limit large-scale implementation,” it added.